Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis.
نویسندگان
چکیده
BACKGROUND Although hepatic metastasectomy is well established for colorectal and neuroendocrine cancer, the approach to hepatic metastases from other sites is not well defined. We sought to examine the management of noncolorectal non-neuroendocrine liver metastases. STUDY DESIGN A retrospective review from 4 major liver centers identified patients who underwent liver resection for noncolorectal non-neuroendocrine metastases between 1990 and 2009. The Kaplan-Meier method was used to analyze survival, and Cox regression models were used to examine prognostic variables. RESULTS There were 420 patients available for analysis. Breast cancer (n = 115; 27%) was the most common primary malignancy, followed by sarcoma (n = 98; 23%), and genitourinary cancers (n = 92; 22%). Crude postoperative morbidity and mortality rates were 20% and 2%, respectively. Overall median survival was 49 months, and 1, 3, and 5-year Kaplan-Meier survival rates were 73%, 50%, and 31%. Survival was not significantly different between the various primary tumor types. Recurrent disease was found after hepatectomy in 66% of patients. In multivariable models, lymphovascular invasion (p = 0.05) and metastases ≥5 cm (p = 0.04) were independent predictors of poorer survival. Median survival was shorter for resections performed between 1990 and 1999 (n = 101, 32 months) when compared with resections between 2000 and 2009 (n = 319, 66 months; p = 0.003). CONCLUSIONS Hepatic metastasectomy for noncolorectal non-neuroendocrine cancers is safe and feasible in selected patients. Lymphovascular invasion and metastases ≥5 cm were found to be associated with poorer survival. Patients undergoing metastasectomy in more recent years appear to be surviving longer, however, the reasons for this are not conclusively determined.
منابع مشابه
PROGRESS IN LIVER TRANSPLANTATION Management of Hepatic Metastases
Although the liver is the most common site of metastatic disease from a variety of tumor types, isolated hepatic metastases most commonly occur from colorectal cancer and, less frequently, from neuroendocrine tumors, gastrointestinal sarcoma, ocular melanoma, and others. Complete evaluation of the extent of metastatic disease, both intrahepatically and extrahepatically, is important before cons...
متن کاملSpontaneous rupture of hepatic metastasis from small cell neuroendocrine carcinoma of maxillary sinus
BACKGROUND Small cell neuroendocrine carcinoma of the maxillary sinus, a rare malignant tumor, has a poor prognosis because of its high incidence of metastasis. Moreover, metastatic cancer-induced hepatic rupture, characterized by hemoperitoneum, is infrequent, although several lines of evidences have reported that a wide variety of other neoplasms can cause this usually fatal manifestation. ...
متن کاملTotally Laparoscopic D2 Subtotal Gastrectomy with Hepatectomy and Cholecystectomy for Gastric Neuroendocrine Tumor with Liver Metastases
Synchronous resection of primary neuroendocrine tumors (NET) with liver metastases remains controversial, although recent studies have demonstrated its safety in select patients. Synchronous laparoscopic gastric and liver resection has been rarely reported. We report the case of a 65-year-old man who underwent successful simultaneous D2 subtotal gastrectomy with hepatectomy and cholecystectomy ...
متن کاملRectal Neuroendocrine Tumor G1 with a Solitary Hepatic Metastatic Lesion
Rectal neuroendocrine tumor (NET) is a relatively rare tumor. NET is classified as G1, G2, or G3 according to the degree of mitosis or Ki-67 proliferation index, which reflect the malignant potential of the tumor, such as metastasis. Advanced cases with metastasis are indicated for chemotherapy treatment. However, the efficacy of chemotherapy is limited. Therefore, resection is considered, even...
متن کاملPrimary hepatic neuroendocrine carcinoma: clinicopathologic analysis of surgical treatment of 12 cases from a single institutional experience
Primary hepatic neuroendocrine carcinoma (PHNEC) is a kind of rarer disease than gastrointestine derived neuroendocrine carcinoma. Therefore, it is difficult to make an accurate diagnosis and determine a proper therapeutic decision. 12 PHNEC patients were admitted to our hospital from November 2011 to June 2015. CT/ MRI, B-ultrasonography and laboratory examination were performed before liver r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of the American College of Surgeons
دوره 214 5 شماره
صفحات -
تاریخ انتشار 2012